1. Answer to Controversy: miR-10a Replacement Approaches Do Not Offer Protection against Chemotherapy-Induced Gonadotoxicity in Mouse Model.
- Author
-
Alexandri C, Stratopoulou CA, and Demeestere I
- Subjects
- Animals, Antineoplastic Agents pharmacology, Apoptosis drug effects, Apoptosis genetics, Cell Proliferation drug effects, Disease Models, Animal, Female, Gene Expression, Liposomes, Mice, MicroRNAs administration & dosage, Ovary drug effects, Ovary metabolism, Ovary pathology, PTEN Phosphohydrolase metabolism, Phosphatidylinositol 3-Kinases metabolism, Primary Ovarian Insufficiency pathology, Signal Transduction drug effects, Transfection, Treatment Outcome, Antineoplastic Agents adverse effects, MicroRNAs genetics, Primary Ovarian Insufficiency etiology, Primary Ovarian Insufficiency prevention & control, RNAi Therapeutics methods
- Abstract
It is well known that chemotherapeutic agents may lead to premature ovarian failure and infertility. Therefore, fertility preservation is highly recommended for female cancer survivors. Despite the currently available techniques, new, non-invasive methods need to be developed to protect the ovarian follicles during oncological treatments. MicroRNAs can be effective tools in this field, as they alter their expression during chemotherapy exposure, and hence they can be useful to minimize the off-target toxicity. Previously, we identified several miRNAs with an important role in newborn mouse ovaries exposed to chemotherapy; among them, the miR-10a was one of the most downregulated miRNAs. Given the controversial role of miR-10a in the ovarian function, we decided to investigate its implication in chemotherapy-induced gonadotoxicity. The downregulated levels of miR-10a were restored by a liposome system conjugated with a mimic miR-10a, and the overexpressed miR-10a prevented the upregulation of the targeted gene, phosphatase and tensin homolog ( Pten ). The apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) Assay and Bax expression quantification, while histological studies were also performed to evaluate the follicle count and development. Our results showed that the miR-10a replacement could not protect the ovaries from chemotherapy-induced apoptosis, whereas the targeting of Pten may affect the follicle activation via the phosphoinositide 3-kinase (PI3K)/PTEN/protein kinase B (AKT) pathway. Consequently, the application of miR-10a in fertility preservation is not recommended, and the role of miR-10a needs to be further elucidated.
- Published
- 2019
- Full Text
- View/download PDF